Severe Hypoglycemia Due to Possible Interaction Between Glibenclamide and Sorafenib in a Patient with Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|8|2|148-152

ISSN： 1574-8863

Source： Current Drug Safety, Vol.8, Iss.2, 2013-04, pp. : 148-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete Response after Short-Term Sorafenib Treatment in a Patient with Lymph Node Metastasis of Hepatocellular Carcinoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-07 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada

By Muszbek Noemi   Shah Sonalee   Carroll Stuart   McDonald Heather   Dale Peter   Maroun Jean   Knox Jennifer  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3559-3569

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 119-125

Karger

Access to resources Recommend Favorite

Interaction between Haemochromatosis and Transferrin Receptor Genes in Hepatocellular Carcinoma

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 317-322

Karger

Access to resources Recommend Favorite

Severe Neutropenia in a Renal Transplant Patient Suggesting an Interaction Between Mycophenolate and Fenofibrate

By  

Current Drug Safety, Vol. 7, Iss. 1, 2012-02 ,pp. : 24-29

Bentham Science Publishers

Access to resources Recommend Favorite